Receptor Tyrosine Kinase Signaling Favors a Protumorigenic State in Breast Cancer Cells by Inhibiting the Adaptive Immune Response-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Receptor Tyrosine Kinase Signaling Favors a Protumorigenic State in Breast Cancer Cells by Inhibiting the Adaptive Immune Response

Published:2010-10-05 Issue:20 Volume:70 Page:7776-7787
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Ursini-Siegel Josie,Cory Sean,Zuo Dongmei,Hardy William R.,Rexhepaj Elton,Lam Sonya,Schade Babette,Jirstrom Karin,Bjur Eva,Piccirillo Ciriaco A.,DeNardo David,Coussens Lisa M.,Brennan Donal J.,Gallagher William M.,Park Morag,Pawson Tony,Hallett Michael,Muller William J.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Receptor tyrosine kinase inhibitors in cancer;Cellular and Molecular Life Sciences;2023-03-22

2. Receptor Tyrosine Kinase Inhibitors in Cancer Immunotherapy;2022-11-22

3. Pan-Cancer Study of SHC-Adaptor Protein 1 (SHC1) as a Diagnostic, Prognostic and Immunological Biomarker in Human Cancer;Frontiers in Genetics;2022-05-02

4. Clinical Potential of Kinase Inhibitors in Combination with Immune Checkpoint Inhibitors for the Treatment of Solid Tumors;International Journal of Molecular Sciences;2021-03-05

5. The SHCA adapter protein cooperates with lipoma-preferred partner in the regulation of adhesion dynamics and invadopodia formation;Journal of Biological Chemistry;2020-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP